RESUMEN
Chronic obstructive pulmonary disease (COPD) is one of the most important and prevalent diseases suffered by the elderly. Evidence exists that its onset and severity might be conditioned by antioxidant status. The aim of the present study was to investigate the relationship between antioxidant status and COPD in institutionalised elderly people. In all, 183 elderly people aged >65 years (twenty-one had COPD and 160 healthy controls) were studied. The subjects' diets were investigated via the use of precise individual weighing for 7 d. Body weight, height, and biceps and triceps skinfold thickness were measured, and body fat (kg) and BMI (kg/m2) were calculated. Serum retinol, α-tocopherol, ß-carotene and vitamin C levels were determined. Subjects with COPD ate less fruits than healthy controls (117 (sd 52) v. 192 (sd 161) g/d), their coverage of the recommended intake of vitamin C was smaller (150 (sd 45) v. 191 (sd 88) %; note that both exceeded 100 %) and their diets had a lower antioxidant capacity (6558 (sd 2381) v. 9328 (sd 5367) mmol trolox equivalent/d). Those with COPD had lower serum vitamin C and α-tocopherol concentrations than healthy controls (32·4 (sd 15·3) v. 41·5 (sd 14·8) µmol/l and 12·1 (sd 3·2) v. 13·9 (sd 2·8) µmol/l, respectively). In addition, subjects with α-tocopherol <14·1µmol/l (50th percentile) were at 6·43 times greater risk of having COPD than those subjects with ≥14·1µmol/l (OR 6·43; 95 % CI 1·17, 35·24; P<0·05), taking sex, age, use of tobacco, body fat and vitamin E intake as covariables. Subjects with COPD had diets of poorer antioxidant quality, especially with respect to vitamins C and E, compared with healthy controls.
Asunto(s)
Antioxidantes/administración & dosificación , Enfermedad Pulmonar Obstructiva Crónica/sangre , Anciano , Anciano de 80 o más Años , Ácido Ascórbico/administración & dosificación , Ácido Ascórbico/sangre , Biomarcadores/sangre , Índice de Masa Corporal , Peso Corporal , Estudios de Casos y Controles , Dieta , Femenino , Frutas , Humanos , Masculino , Vitamina E/administración & dosificación , Vitamina E/sangre , alfa-Tocoferol/administración & dosificación , alfa-Tocoferol/sangre , beta Caroteno/administración & dosificación , beta Caroteno/sangreRESUMEN
UNLABELLED: The aim of this work was to study the relationship between dietary total antioxidant capacity (TAC) and current asthma in a group of Spanish schoolchildren. A total of 78 Spanish schoolchildren (26 asthmatic and 52 healthy controls) were randomly selected from a cohort of 564 children (9-12 years of age). The weight and height of all subjects were recorded. A questionnaire, completed by the subjects' parents, was used to obtain personal and health information. Current asthma was established when children had ever had asthma, they had been diagnosed with asthma by a physician, and they had been treated with medications at some time in the previous 12 months. Food intake was monitored using a 3-day food record. All consumed foods were converted into energy and nutrients. Dietary TAC was evaluated using the ferric reducing antioxidant power (FRAP), radical-trapping antioxidant parameter (TRAP), and Trolox equivalent antioxidant capacity (TEAC) assays. The TAC measured using all the assays was significantly lower in children with asthma than in children without this condition (2.95 (2.10-3.75) mmol Fe(II)/day vs. 3.70 (3.08-4.49) mmol Fe(II)/day, p < 0.01; 1.50 (1.06-2.05) mmol Trolox equivalents/day vs. 2.10 (1.40-2.65) mmol Trolox equivalents/day, p < 0.05; and 1.60 (1.08-2.00) mmol Trolox equivalents/day vs. 1.85 (1.50-2.68) mmol Trolox equivalents/day, p < 0.05 for FRAP, TEAC, and TRAP, respectively). After adjusting for energy intake, children with FRAP values higher than 3.5 mmol Fe(II)/day (p50) and TEAC values higher than 1.9 mmol Trolox equivalents/day (p50) had 22.6 and 35.0 %, respectively, lower likelihood of suffering asthma episodes than children with lower values. When logistic regression analysis was performed separately for children with nonsmoker and smoker (at least one) parents, the association between dietary TAC and asthma was only observed in the nonsmoker group (OR = 0.257, 95 % CI = 0.107-0.618, p = 0.002 for FRAP; OR = 0.212, 95 % CI = 0.069-0.639, p = 0.006 for TEAC; and OR = 0.264, 95 % CI = 0.091-0.769, p = 0.015 for TRAP assay). CONCLUSION: Dietary TAC may have a favorable role in asthma in children and, specially, in those with nonsmoker parents.
Asunto(s)
Antioxidantes/análisis , Asma/epidemiología , Dieta , Análisis de los Alimentos , Estudios de Casos y Controles , Niño , Registros de Dieta , Conducta Alimentaria , Femenino , Encuestas Epidemiológicas , Humanos , Masculino , Población , España/epidemiología , Encuestas y CuestionariosRESUMEN
INTRODUCTION: To analyze the prevalence of disability among patients with COPD as compared to people without this lung disease and to identify sociodemographic and health factors associated with these physical limitations. METHODS: We performed a cross-sectional study based on data taken from the European Health Interview Survey for Spain (EHISS) 2009. The survey included adults aged 40 to 79 years (n = 13624). We identified patients with COPD using a direct question from the survey. The main study variable was disability, including basic activities of daily living (ADLs), instrumental activities (IADLs), and mobility disability (MD). Independent variables analyzed included socio-demographic characteristics, self-perceived health status, presence of mental disease and co-morbid chronic conditions and lifestyles. RESULTS: The overall prevalence of self-reported COPD was 7.2%. The total prevalence of ADL, IADL and MD was higher among men suffering COPD than among the population without this disease (16.39% vs. 4.91%; 27.70% vs. 12.45%; 48.94% vs. 17.46% respectively). These significant differences were also observed among women with equivalent figures of: 23.25% vs. 8.71%; 31.03% vs. 10.53%; 64.83% vs. 34.08%. Being older, having a self-perceived health status of "fair/poor/very poor" and suffering from mental disease (anxiety and/or depression) were factors associated with a higher probability of reporting any disability in both men and women suffering from COPD. CONCLUSIONS: Higher rates of disability were seen among COPD patients compared to the general population. Among COPD patients older age, depression, anxiety and worse self-rated health were associated with higher disability.
Asunto(s)
Actividades Cotidianas , Trastornos de Ansiedad/epidemiología , Trastorno Depresivo/epidemiología , Estado de Salud , Limitación de la Movilidad , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Adulto , Factores de Edad , Anciano , Estudios de Casos y Controles , Comorbilidad , Estudios Transversales , Escolaridad , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Obesidad/epidemiología , Prevalencia , Factores de Riesgo , España/epidemiologíaRESUMEN
INTRODUCTION: Obstructive sleep apnea (OSA) increases the risk of type 2 diabetes, and hyperinsulinemia. Pregnancy increases the risk of OSA; however, the relationship between OSA and gestational diabetes mellitus (GDM) is unclear. We aimed (1) to evaluate OSA prevalence in GDM patients; (2) to assess the association between OSA and GDM; and (3) to determine the relationships between sleep parameters with insulin resistance (IR). METHODS: A total of 177 consecutive women (89 with GDM, 88 controls) in the third trimester of pregnancy underwent a hospital polysomnography. OSA was defined when the apnea-hypopnea index (AHI) was ≥5h-1. RESULTS: Patients with GDM had higher pregestational body mass index (BMI) and neck circumference than controls, but no differences in snoring or OSA-symptoms, or AHI (3.2±6.0 vs. 1.9±2.7h-1, p=.069). OSA prevalence was not significantly different in both groups. We did not identify OSA as a GDM risk factor in the crude analysis 1.65 (95%CI: 0.73-3.77; p=.232). Multiple regression showed that total sleep time (TST), TST spent with oxygen saturation<90% (T90), and maximum duration of respiratory events as independent factors related with homeostasis model assessment of IR, while T90 was the only independent determinant of quantitative insulin sensitivity check index. CONCLUSION: OSA prevalence during the third trimester of pregnancy was not significantly different in patients with GDM than without GDM, and no associations between OSA and GDM determinants were found. We identified T90 and obstructive respiratory events length positive-related to IR, while TST showed an inverse relationship with IR in pregnant women.
RESUMEN
Obstructive sleep apnea (OSA) is a recognized risk factor for the development of diabetic kidney disease (DKD). Our objectives were to compare the urinary albumin-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) of patients with DKD according to OSA severity, and to evaluate the contribution of sleep parameters to their renal function. In a multicenter, observational, cross-sectional study, 214 patients with DKD were recruited. After a sleep study, UACR and eGFR were measured, as well as serum creatinine, fasting glucose, glycated hemoglobin, insulin resistance, lipid profile and C-reactive protein. UACR was higher in severe OSA patients (920 ± 1053 mg/g) than in moderate (195 ± 232 mg/g, p < 0.001) or mild OSA/non-OSA subjects (119 ± 186 mg/g, p < 0.001). At the same time, eGFR showed an OSA severity-dependent reduction (48 ± 23 vs. 59 ± 21 vs. 73 ± 19 ml/min per 1.73 m2, respectively; p < 0.001). Apnea-hypopnea index (AHI and desaturation index (ODI) were identified as independent predictors for UACR and eGFR, respectively. Therefore, in patients with DKD under optimized treatment, severe OSA is associated with a higher UACR and a lower eGFR, reflecting an additional contribution to the impairment of their renal function, although no causality can be inferred.
Asunto(s)
Nefropatías Diabéticas/complicaciones , Nefropatías Diabéticas/fisiopatología , Pruebas de Función Renal , Apnea Obstructiva del Sueño/complicaciones , Apnea Obstructiva del Sueño/fisiopatología , Anciano , Albuminuria/complicaciones , Albuminuria/fisiopatología , Creatinina/orina , Femenino , Tasa de Filtración Glomerular/fisiología , Humanos , Riñón/patología , Riñón/fisiopatología , Modelos Lineales , Masculino , Análisis Multivariante , Sueño/fisiologíaRESUMEN
Background: Obstructive sleep apnea (OSA) is prevalent in pregnancy and it is associated with adverse pregnancy-related outcomes such as gestational diabetes, pre-eclampsia, and low birth weight. Maternal systemic inflammation is proposed to be one of the main intermediate mechanisms. However, the effects of OSA on systemic inflammation are unknown in normal pregnancy. Methods: Women in the 3rd trimester underwent hospital polysomnography to evaluate whether OSA increases systemic inflammation in normal pregnancy and its potential association with adverse fetal outcomes. OSA was defined as an apnea-hypopnea index (AHI) of ≥ 5 h-1. Plasma cytokines levels (TNF-α, IL-1ß, IL-6, IL-8, and IL-10) were determined by multiple immunoassays. Results: We included 11 patients with OSA and 22 women with AHI < 5 h-1, who were homogeneous in age, and body mass index (BMI). Women with OSA had significant higher levels of TNF-α, IL-1ß, IL-8, and IL-10. We found significant correlations between AHI during REM and TNF-α (r = 0.40), IL-1ß (r = 0.36), IL-6 (r = 0.52), IL-8 (r = 0.43), between obstructive apnea index and TNF-α (r = 0.46) and between AHI and IL-1ß (r = 0.43). We also found that CT90% was related to IL-8 (r = 0.37). There were no significant differences in neonatal characteristics; however, we found inverse correlations between TNF-α and IL-8 with birth weight (both r = -0.48), while IL-8 showed a significant inverse relationship with neonatal gestational age (r = -0.48). Conclusions: OSA in our normal pregnancy population was associated with higher systemic inflammation, which was related to obstructive events, especially during REM sleep. Moreover, systemic inflammation was inversely correlated with neonatal birth weight and age.
RESUMEN
INTRODUCTION: Obstructive sleep apnea (OSA) increases the risk of type 2 diabetes, and hyperinsulinemia. Pregnancy increases the risk of OSA; however, the relationship between OSA and gestational diabetes mellitus (GDM) is unclear. We aimed (1) to evaluate OSA prevalence in GDM patients; (2) to assess the association between OSA and GDM; and (3) to determine the relationships between sleep parameters with insulin resistance (IR). METHODS: A total of 177 consecutive women (89 with GDM, 88 controls) in the third trimester of pregnancy underwent a hospital polysomnography. OSA was defined when the apnea-hypopnea index (AHI) was ≥5h-1. RESULTS: Patients with GDM had higher pregestational body mass index (BMI) and neck circumference than controls, but no differences in snoring or OSA-symptoms, or AHI (3.2±6.0 vs. 1.9±2.7h-1, p=.069). OSA prevalence was not significantly different in both groups. We did not identify OSA as a GDM risk factor in the crude analysis 1.65 (95%CI: 0.73-3.77; p=.232). Multiple regression showed that total sleep time (TST), TST spent with oxygen saturation<90% (T90), and maximum duration of respiratory events as independent factors related with homeostasis model assessment of IR, while T90 was the only independent determinant of quantitative insulin sensitivity check index. CONCLUSION: OSA prevalence during the third trimester of pregnancy was not significantly different in patients with GDM than without GDM, and no associations between OSA and GDM determinants were found. We identified T90 and obstructive respiratory events length positive-related to IR, while TST showed an inverse relationship with IR in pregnant women.
RESUMEN
INTRODUCTION AND OBJECTIVES: Adenotonsillectomy is a surgery to treat recurrent tonsillitis or obstructive sleep apnoea syndrome (OSAS). It is considered a safe procedure, with few complications. Moreover, patients over 3 years and without comorbidities do not present a higher rate of respiratory adverse events after the immediate postoperative period, and do not need systematic admission to a paediatric intensive care unit (PICU), regardless of their OSAS severity. The aim of this study is to reanalyse the situation, including patients under the age of 3 years, for whom there are fewer available data, to confirm that this trend has not changed. METHODS: A retrospective observational study was performed, including all adenotonsillectomised children in our hospital over 5 years. RESULTS: 418 adenotonsillectomised children were included, 56.7% due to recurrent tonsillitis, and 43.3% because of OSAS. Only 24 patients (5%7%) experienced adverse events, of whom 1.2% had vomiting, 3.1% bleeding, and 1.4% respiratory events. All the respiratory events occurred in the operating theatre or in the post-anaesthetic unit, most frequently in children with severe OSAS, while the tonsillitis group had more bleeding (P=.046). No differences in complications were observed according to age (P=0.174), but the group of patients under three years was relatively small. CONCLUSIONS: No differences were found in the percentage of complications between the two groups. Although the OSAS group exhibited more respiratory events, these occurred in the immediate postoperative period; otherwise, there was a higher risk of bleeding in the tonsillitis group. These results support the findings indicating that routine PICU admission is not required for these patients.
Asunto(s)
Adenoidectomía/efectos adversos , Complicaciones Posoperatorias/etiología , Apnea Obstructiva del Sueño/cirugía , Tonsilectomía/efectos adversos , Tonsilitis/cirugía , Adenoidectomía/estadística & datos numéricos , Factores de Edad , Peso Corporal , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Complicaciones Posoperatorias/clasificación , Hemorragia Posoperatoria/etiología , Náusea y Vómito Posoperatorios/etiología , Recurrencia , Estudios Retrospectivos , Tonsilectomía/estadística & datos numéricosRESUMEN
OBJECTIVE: Snoring is a common reason for referral to a sleep unit. Although there are several instruments to measure snoring, there is no gold standard for this purpose. In this study, we determine the diagnostic accuracy of the cannula as compared with the microphone, which are the two most commonly used tools. STUDY DESIGN: We performed a cross-sectional study of 75 patients who underwent baseline home sleep apnea testing for any reason. METHODS: Snore intensity and percentage were assessed during Home sleep-apnea testing via nasal cannula and microphone in all patients. We performed a complete diagnostic accuracy analysis, assuming the microphone to be the reference instrument use in order to compare it with the cannula. RESULTS: The intra-class correlation coefficient between the cannula and microphone for the percentage of snoring was 0.25. The Bland Bland-Altman analysis to determine the agreement regarding the percentage of snoring showed a lower limit of -57.73 and an upper limit of 20.30. A linear regression analysis of the differences produced a negative slope of -0.86. The receiver operating characteristic curve for severe snoring using the cannula produced an area under the curve of 0.67 (P = 0.019). The cannula showed a sensitivity of 57.89 and a specificity of 73.21. CONCLUSION: The nasal cannula showed poor reliability and accuracy for measuring snoring. LEVEL OF EVIDENCE: 2b. Laryngoscope, 127:2886-2890, 2017.
Asunto(s)
Síndromes de la Apnea del Sueño/diagnóstico , Ronquido/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Cánula , Estudios Transversales , Técnicas de Diagnóstico del Sistema Respiratorio/instrumentación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Síndromes de la Apnea del Sueño/complicaciones , Ronquido/etiologíaRESUMEN
Introduction: Obstructive sleep apnea (OSA) increases the risk of type 2 diabetes, and hyperinsulinemia. Pregnancy increases the risk of OSA; however, the relationship between OSA and gestational diabetes mellitus (GDM) is unclear. We aimed (1) to evaluate OSA prevalence in GDM patients; (2) to assess the association between OSA and GDM; and (3) to determine the relationships between sleep parameters with insulin resistance (IR).MethodsA total of 177 consecutive women (89 with GDM, 88 controls) in the third trimester of pregnancy underwent a hospital polysomnography. OSA was defined when the apnea-hypopnea index (AHI) was ≥5h−1.ResultsPatients with GDM had higher pregestational body mass index (BMI) and neck circumference than controls, but no differences in snoring or OSA-symptoms, or AHI (3.2±6.0 vs. 1.9±2.7h−1, p=.069). OSA prevalence was not significantly different in both groups. We did not identify OSA as a GDM risk factor in the crude analysis 1.65 (95%CI: 0.733.77; p=.232). Multiple regression showed that total sleep time (TST), TST spent with oxygen saturation<90% (T90), and maximum duration of respiratory events as independent factors related with homeostasis model assessment of IR, while T90 was the only independent determinant of quantitative insulin sensitivity check index.ConclusionOSA prevalence during the third trimester of pregnancy was not significantly different in patients with GDM than without GDM, and no associations between OSA and GDM determinants were found. We identified T90 and obstructive respiratory events length positive-related to IR, while TST showed an inverse relationship with IR in pregnant women. (AU)
Introducción: La apnea obstructiva del sueño (AOS) aumenta el riesgo de diabetes tipo 2 e hiperinsulinemia. El embarazo aumenta el riesgo de AOS; sin embargo, la relación entre la AOS y la diabetes mellitus gestacional (DMG) no está clara. Nuestros objetivos fueron (1) evaluar la prevalencia de AOS en pacientes con DMG; (2) evaluar la asociación entre la AOS y la DMG; y (3) determinar las relaciones entre los parámetros del sueño y la resistencia a la insulina (RI).MétodosUn total de 177 mujeres seleccionadas consecutivamente (89 de ellas con DMG, 88 controles) en el tercer trimestre del embarazo se sometieron a una polisomnografía hospitalaria. Se clasificó como AOS un índice de apnea-hipopnea (IAH) de ≥5h-1.ResultadosLas pacientes con DMG presentaban un índice de masa corporal (IMC) pregestacional y una circunferencia del cuello más altos que los controles, pero no hubo diferencias en los ronquidos, otros síntomas de AOS o el IAH (3,2±6,0 frente a 1,9±2,7h-1, p=0,069). La diferencia en la prevalencia de AOS entre ambos grupos no fue significativa. No identificamos la AOS como un factor de riesgo de DMG en el análisis bruto (1,65; IC del 95%: 0,73-3,77; p=0,232). Mediante regresión múltiple se determinó que el tiempo total de sueño (TST), el TST pasado con una saturación de oxígeno <90% (T90) y la duración máxima de los eventos respiratorios eran factores independientes relacionados con el Homeostasis Model Assessment of IR (HOMA-IR), mientras que el T90 fue el único determinante independiente del Quantitative Insulin Sensitivity Check Index (QUICKI).ConclusiónLa diferencia de prevalencia de AOS durante el tercer trimestre del embarazo no fue significativa entre las pacientes con DMG y aquellas sin DMG, y no se encontraron asociaciones entre los factores asociados a AOS y DMG. (AU)
Asunto(s)
Humanos , Femenino , Diabetes Gestacional , Embarazo en Diabéticas , Apnea Obstructiva del Sueño , Resistencia a la Insulina , Síndromes de la Apnea del SueñoRESUMEN
Asthma is a chronic disease characterized by airway inflammation and bronchoconstriction. There are different factors that can favor this process, but the role of diet is especially important. Thus, inadequate nutritional status in some nutrients causes alterations in immune function and antioxidant defense mechanisms that may facilitate the onset of inflammatory processes in the pulmonary system. Thus, intervention studies with antioxidant vitamins have shown mixed results. Nevertheless, having in mind the low consumption of fruits and vegetables and the low intake of antioxidant nutrients of the population, a first step could be to approximate the diet to the theoretical ideal to reach the recommended intakes. Furthermore, it is important follow an adequate diet during the pregnancy because during this period the diet affects fetal development, which can be related to the suffering of asthma in childhood, and even in adulthood. In addition, in relation with other less studied nutrients, such as vitamin D and those nutrients methyl donors, would be interesting to conduct randomized controlled trials in people with risk of asthma or with established asthma to test their effect.
El asma es una enfermedad crónica caracterizada por una obstrucción reversible de las vías aéreas debido a una inflamación de las mismas. Existen diferentes factores que pueden favorecer este proceso, pero el papel de la dieta es especialmente importante. De esta manera, una dieta incorrecta y la situación inadecuada en algunos nutrientes produce alteraciones de la función inmunitaria y de los mecanismos de defensa antioxidante que pueden facilitar la aparición de procesos inflamatorios en el árbol bronquial. En este sentido, con relación a los estudios de intervención con vitaminas antioxidantes, aunque en general han dado resultados variados, si se tiene en cuenta el bajo consumo de frutas y verduras de la población, así como la baja ingesta de nutrientes antioxidantes encontrados en un elevado porcentaje de la misma, un primer paso podría ser aproximar la dieta al ideal aconsejado y cubrir las ingestas recomendadas de dichos nutrientes. Hay que resaltar la importancia de cuidar la dieta durante el embarazo, ya que durante este periodo la dieta influye sobre el desarrollo fetal, que puede ser clave para sufrir asma o no en la edad infantil e incluso en la edad adulta. Además, con relación a otros nutrientes menos estudiados, como la vitamina D y aquellos nutrientes donadores de grupos metilo, sería interesante llevar a cabo ensayos clínicos controlados y aleatorizados en población con riesgo de presentar asma, o con asma ya establecido, para comprobar su efecto.
Asunto(s)
Asma/fisiopatología , Estado Nutricional , Adulto , Asma/epidemiología , Dieta , Conducta Alimentaria , Humanos , Micronutrientes , PrevalenciaAsunto(s)
Eritrocitos/metabolismo , Apnea Obstructiva del Sueño/sangre , Biomarcadores/sangre , Estudios de Casos y Controles , Niño , Preescolar , Índices de Eritrocitos , Femenino , Humanos , Masculino , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Apnea Obstructiva del Sueño/diagnósticoRESUMEN
No disponible
Asunto(s)
Humanos , Preescolar , Niño , Apnea Obstructiva del Sueño/sangre , Índice de Severidad de la Enfermedad , Estudios de Casos y Controles , Estudios Retrospectivos , PolisomnografíaRESUMEN
INTRODUCTION: Obesity is associated with 2 closely related respiratory diseases: obesity hypoventilation syndrome (OHS) and obstructive sleep apnea-hypopnea syndrome (OSAHS). It has been shown that noninvasive ventilation during sleep produces clinical and functional improvement in these patients. The long-term survival rate with this treatment, and the difference in clinical progress in OHS patients with and without OSAHS are analyzed. METHODOLOGY: Longitudinal, observational study with a cohort of patients diagnosed with OHS, included in a home ventilation program over a period of 12 years, divided into 2 groups: pure OHS and OSAHS-associated OHS. Bi-level positive airway pressure ventilation was administered. During the follow-up period, symptoms, exacerbations and hospitalizations, blood gas tests and pulmonary function tests, and survival rates were monitored and compared. RESULTS: Eighty-three patients were eligible for analysis, 60 women (72.3%) and 23 men (27.7%), with a mean survival time of 8.47 years. Fifty patients (60.2%) were included in the group without OSAHS (OHS) and 33 (39.8%) in the OSAHS-associated OHS group (OHS-OSAHS). PaCO2 in the OHS group was significantly higher than in the OHS-OSAHS group (P<.01). OHS patients also had a higher hospitalization rate (P<.05). There was a significant improvement in both groups in FEV1 and FVC, and no differences between groups in PaCO2 and PaO2 values. There were no differences in mortality between the 2 groups, but low FVC values were predictive of mortality. CONCLUSIONS: The use of mechanical ventilation in patients with OHS, with or without OSAHS, is an effective treatment for the correction of blood gases and functional alterations and can achieve prolonged survival rates.
Asunto(s)
Presión de las Vías Aéreas Positiva Contínua , Síndrome de Hipoventilación por Obesidad/terapia , Anciano , Dióxido de Carbono/sangre , Femenino , Volumen Espiratorio Forzado , Servicios de Atención de Salud a Domicilio , Humanos , Hipercapnia/etiología , Hipercapnia/terapia , Masculino , Persona de Mediana Edad , Síndrome de Hipoventilación por Obesidad/sangre , Síndrome de Hipoventilación por Obesidad/mortalidad , Síndrome de Hipoventilación por Obesidad/fisiopatología , Oxígeno/sangre , Presión Parcial , Cooperación del Paciente , Polisomnografía , Pronóstico , Estudios Prospectivos , Capacidad VitalRESUMEN
Pulmonary veno-occlusive disease (PVOD) is a subgroup of pulmonary arterial hypertension with a poor prognosis. The diagnosis is usually delayed and treatment options other than lung transplantation are unfortunately limited. We report the case of 51-year-old female gardener diagnosed with PVOD by open lung biopsy before her death. Although there are many reported cases of hepatic veno-occlusive disease due to toxic agents present in nature, such as pyrrolizidine alkaloid exposure, to date this has not been linked to PVOD.
Asunto(s)
Jardinería , Exposición Profesional , Enfermedad Veno-Oclusiva Pulmonar/etiología , Alcaloides de Pirrolicidina/toxicidad , Biopsia , Diagnóstico Tardío , Progresión de la Enfermedad , Disnea/etiología , Resultado Fatal , Femenino , Humanos , Hipertensión Pulmonar/etiología , Persona de Mediana Edad , Plantas/química , Enfermedad Veno-Oclusiva Pulmonar/complicaciones , Enfermedad Veno-Oclusiva Pulmonar/diagnóstico , Enfermedad Veno-Oclusiva Pulmonar/diagnóstico por imagen , Enfermedad Veno-Oclusiva Pulmonar/patología , Tomografía Computarizada por Rayos XRESUMEN
OBJECTIVE: We aim to analyze changes in incidence, comorbidity profile, length of hospital stay (LOHS), costs and in-hospital mortality (IHM) of patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) over a 5-year study period in Spain. METHODS: We selected all hospital admissions for AE-COPD between 2006 and 2010 from the National Hospital Discharge Database covering the entire population of Spain. RESULTS: We identified a total of 215,835 patients. Overall crude incidence had decreased from 2.9 to 2.4 exacerbations of COPD per 10,000 inhabitants from 2006 to 2010 (p < 0.001). In 2006, 17.9% of patients had a Charlson Index >2 and in 2010, the prevalence had increased to 25.0% (p < 0.001). Regarding to treatment, we detected a significant increase in the use of non-invasive ventilation from 2.1% in 2006 to 5.3% in 2010 (p < 0.001). The median LOHS was 7 days in 2006 and it remained stable until 2010. During the period studied, the mean cost per patient increased from 3747 to 4129 Euros. Multivariate analysis showed that incidence of hospitalizations for AE-COPD and IHM had significantly decreased from 2006 to 2010. CONCLUSIONS: The current study provides data indicating a decrease in incidence of hospital admissions for AE-COPD in Spain from 2006 to 2010 with concomitant reduction in IHM, despite increasing comorbidity during this period, with no variations in LOHS. The mean cost per patient has risen significantly.
Asunto(s)
Hospitalización/tendencias , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Enfermedad Aguda , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Comorbilidad , Femenino , Costos de Hospital/estadística & datos numéricos , Costos de Hospital/tendencias , Humanos , Incidencia , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Enfermedad Pulmonar Obstructiva Crónica/economía , Enfermedad Pulmonar Obstructiva Crónica/terapia , Respiración Artificial/métodos , Respiración Artificial/estadística & datos numéricos , Respiración Artificial/tendencias , Estaciones del Año , Distribución por Sexo , España/epidemiologíaRESUMEN
El asma es una enfermedad crónica caracterizada por una obstrucción reversible de las vías aéreas debido a una inflamación de las mismas. Existen diferentes factores que pueden favorecer este proceso, pero el papel de la dieta es especialmente importante. De esta manera, una dieta incorrecta y la situación inadecuada en algunos nutrientes produce alteraciones de la función inmunitaria y de los mecanismos de defensa antioxidante que pueden facilitar la aparición de procesos inflamatorios en el árbol bronquial. En este sentido, con relación a los estudios de intervención con vitaminas antioxidantes, aunque en general han dado resultados variados, si se tiene en cuenta el bajo consumo de frutas y verduras de la población, así como la baja ingesta de nutrientes antioxidantes encontrados en un elevado porcentaje de la misma, un primer paso podría ser aproximar la dieta al ideal aconsejado y cubrir las ingestas recomendadas de dichos nutrientes. Hay que resaltar la importancia de cuidar la dieta durante el embarazo, ya que durante este periodo la dieta influye sobre el desarrollo fetal, que puede ser clave para sufrir asma o no en la edad infantil e incluso en la edad adulta. Además, con relación a otros nutrientes menos estudiados, como la vitamina D y aquellos nutrientes donadores de grupos metilo, sería interesante llevar a cabo ensayos clínicos controlados y aleatorizados en población con riesgo de presentar asma, o con asma ya establecido, para comprobar su efecto (AU)
Asthma is a chronic disease characterized by airway inflammation and bronchoconstriction. There are different factors that can favor this process, but the role of diet is especially important. Thus, inadequate nutritional status in some nutrients causes alterations in immune function and antioxidant defense mechanisms that may facilitate the onset of inflammatory processes in the pulmonary system. Thus, intervention studies with antioxidant vitamins have shown mixed results. Nevertheless, having in mind the low consumption of fruits and vegetables and the low intake of antioxidant nutrients of the population, a first step could be to approximate the diet to the theoretical ideal to reach the recommended intakes. Furthermore, it is important follow an adequate diet during the pregnancy because during this period the diet affects fetal development, which can be related to the suffering of asthma in childhood, and even in adulthood. In addition, in relation with other less studied nutrients, such as vitamin D and those nutrients methyl donors, would be interesting to conduct randomized controlled trials in people with risk of asthma or with established asthma to test their effect (AU)
Asunto(s)
Humanos , Masculino , Femenino , Asma/dietoterapia , Asma/epidemiología , Asma/prevención & control , Estado Nutricional/fisiología , Nutrientes/prevención & control , Nutrientes/estadística & datos numéricos , Selenio/uso terapéutico , Ácido Ascórbico/uso terapéutico , Nutrientes/métodos , Factores Inmunológicos/análisis , Factores Inmunológicos/uso terapéutico , Sexualidad/fisiología , Obesidad/complicaciones , Vitamina E/uso terapéutico , Vitamina A/uso terapéutico , Zinc/uso terapéutico , Antioxidantes/uso terapéuticoRESUMEN
INTRODUCCIÓN Y OBJETIVOS: La adenoamigdalectomía es una cirugía indicada por amigdalitis recurrentes e igualmente por síndrome de apnea-hipopnea del sueño (SAHS). Es considerada segura y con pocas complicaciones. Así, en pacientes mayores de 3 años y sin comorbilidades no hay más complicaciones respiratorias (fuera del postoperatorio inmediato), por lo que no precisan la hospitalización rutinaria en la unidad de cuidados intensivos pediátricos, independientemente de la gravedad del SAHS. El objetivo de este estudio es reanalizar la situación, para comprobar que esta tendencia se mantiene, poniendo especial énfasis en menores de 3 años, subgrupo donde hay menos datos disponibles. MÉTODOS: Estudio retrospectivo observacional, incluyendo los niños adenoamigdalectomizados en nuestro centro durante 5 años. RESULTADOS: Se operaron 418 niños (56,7% por amigdalitis y 43,3% por SAHS). Solo 24 (5,7%) tuvieron complicaciones: un 1,2% vómitos, un 3,1% sangrados y un 1,4% complicaciones respiratorias. Estas últimas ocurrieron siempre en quirófano o recuperación postanestésica y más frecuentemente en SAHS grave, mientras que las amigdalitis tuvieron más sangrados (p = 0,046). No hay diferencias por edad (p = 0,174), aunque el subgrupo de menores de 3 años sigue siendo más pequeño. CONCLUSIONES: No encontramos diferencias en el porcentaje de complicaciones entre SAHS y amigdalitis. Las amigdalitis tienen más sangrados, y el SAHS grave más complicaciones respiratorias, pero siempre en el postoperatorio inmediato en nuestra serie. Estos datos apoyan la hipótesis previa de no ingresar rutinariamente en la unidad de cuidados intensivos pediátricos salvo en los casos anteriormente mencionados
INTRODUCTION AND OBJECTIVES: Adenotonsillectomy is a surgery to treat recurrent tonsillitis or obstructive sleep apnoea syndrome (OSAS). It is considered a safe procedure, with few complications. Moreover, patients over 3 years and without comorbidities do not present a higher rate of respiratory adverse events after the immediate postoperative period, and do not need systematic admission to a paediatric intensive care unit (PICU), regardless of their OSAS severity. The aim of this study is to reanalyse the situation, including patients under the age of 3 years, for whom there are fewer available data, to confirm that this trend has not changed. METHODS: A retrospective observational study was performed, including all adenotonsillectomised children in our hospital over 5 years. RESULTS: 418 adenotonsillectomised children were included, 56.7% due to recurrent tonsillitis, and 43.3% because of OSAS. Only 24 patients (5%7%) experienced adverse events, of whom 1.2% had vomiting, 3.1% bleeding, and 1.4% respiratory events. All the respiratory events occurred in the operating theatre or in the post-anaesthetic unit, most frequently in children with severe OSAS, while the tonsillitis group had more bleeding (P = .046). No differences in complications were observed according to age (P = 0.174), but the group of patients under three years was relatively small. CONCLUSIONS: No differences were found in the percentage of complications between the two groups. Although the OSAS group exhibited more respiratory events, these occurred in the immediate postoperative period; otherwise, there was a higher risk of bleeding in the tonsillitis group. These results support the findings indicating that routine PICU admission is not required for these patients
Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Tonsilectomía/métodos , Complicaciones Posoperatorias , Síndromes de la Apnea del Sueño/complicaciones , Infecciones/complicaciones , Tonsilectomía/efectos adversos , Estudios Retrospectivos , Tonsilitis/complicaciones , Tonsilitis/cirugía , Antropometría , Polisomnografía/métodos , Modelos Logísticos , Oportunidad Relativa , Intervalos de ConfianzaRESUMEN
Introducción: Desde el punto de vista respiratorio, la obesidad se asocia con 2 enfermedades muy relacionadas: el síndrome de obesidad-hipoventilación (SOH) y el síndrome de apnea-hipopnea del sueño (SAHS). Se ha demostrado que el tratamiento con ventilación mecánica no invasiva durante el sueño produce una mejoría clínica y funcional en estos pacientes. Analizamos a largo plazo la supervivencia con este tratamiento, y la diferencia en la evolución entre pacientes con SOH con y sin SAHS asociado. Metodología: Estudio longitudinal, observacional, de una cohorte de pacientes diagnosticados de SOH e incluidos en un programa de ventilación domiciliaria a lo largo de 12 años, distribuidos en 2 grupos: SOH puro y SOH asociado a SAHS. La ventilación se llevó a cabo con ventiladores de presión positiva continua binivel. Durante el tiempo de seguimiento se monitorizó y comparó su situación clínica (síntomas, exacerbaciones e ingresos), gasométrica y funcional, así como su supervivencia. Resultados: Ochenta y tres pacientes fueron válidos para el análisis, 60 mujeres (72,3%) y 23 hombres (27,7%), con una media de supervivencia de 8,47 años. Cincuenta pacientes (60,2%) fueron incluidos en el grupo sin SAHS (SOH) y 33 (39,8%) en el grupo con SAHS (SOH-SAHS). La PaCO2 del grupo SOH era significativamente mayor que la del grupo SOH-SAHS (p < 0,01), y también presentaban más hospitalizaciones (p < 0,05). Existió una mejoría significativa en ambos grupos en FEV1 y FVC, y en los valores de PaCO2 y PaO2, sin diferencias entre los grupos. Mientras que no se apreciaron diferencias en la supervivencia relacionadas con el subgrupo diagnóstico, valores bajos de FVC sí constituían un factor predictivo de mortalidad. Conclusiones: El uso de ventilación domiciliaria en pacientes con SOH con o sin SAHS es un tratamiento eficaz que corrige las alteraciones gasométricas y funcionales y permite alcanzar tiempos prolongados de supervivencia
Introduction: Obesity is associated with 2 closely related respiratory diseases: obesity hypoventilation syndrome (OHS) and obstructive sleep apnea-hypopnea syndrome (OSAHS). It has been shown that noninvasive ventilation during sleep produces clinical and functional improvement in these patients. The long-term survival rate with this treatment, and the difference in clinical progress in OHS patients with and without OSAHS are analyzed. Methodology: Longitudinal, observational study with a cohort of patients diagnosed with OHS, included in a home ventilation program over a period of 12 years, divided into 2 groups: pure OHS and OSAHS associated OHS. Bi-level positive airway pressure ventilation was administered. During the follow-up period, symptoms, exacerbations and hospitalizations, blood gas tests and pulmonary function tests, and survival rates were monitored and compared Results: Eighty-three patients were eligible for analysis, 60 women (72.3%) and 23 men (27.7%), with a mean survival time of 8.47 years. Fifty patients (60.2%) were included in the group without OSAHS (OHS) and 33 (39.8%) in the OSAHS-associated OHS group (OHS-OSAHS). PaCO2 in the OHS group was significantly higher than in the OHS-OSAHS group (P < .01). OHS patients also had a higher hospitalization rate (P < .05). There was a significant improvement in both groups in FEV1 and FVC, and no differences between groups in PaCO2 and PaO2 values. There were no differences in mortality between the 2 groups, but low FVC values were predictive of mortality. Conclusions: The use of mechanical ventilation in patients with OHS, with or without OSAHS, is an effective treatment for the correction of blood gases and functional alterations and can achieve prolonged survival rates
Asunto(s)
Humanos , Obesidad/complicaciones , Hipoventilación/complicaciones , Ventilación no Invasiva/métodos , Síndromes de la Apnea del Sueño/epidemiología , Tiempo/estadística & datos numéricos , Estudios Longitudinales , Estudios de Casos y Controles , Análisis de SupervivenciaRESUMEN
La enfermedad pulmonar venooclusiva es una forma infrecuente de hipertensión arterial pulmonar y su pronóstico es sombrío. El diagnóstico suele ser tardío y el único tratamiento curativo en la actualidad es el trasplante pulmonar. Presentamos el caso de una mujer jardinera de 51 años cuyo diagnóstico se obtuvo por biopsia pulmonar abierta realizada previamente a su fallecimiento. Si bien existen casos reportados de enfermedad venooclusiva hepática secundaria a agentes tóxicos presentes en la naturaleza, como el alcaloide pirrolizidina, hasta el momento no se han relacionado con la enfermedad a nivel pulmonar
Pulmonary veno-occlusive disease (PVOD) is a subgroup of pulmonary arterial hypertension with a poor prognosis. The diagnosis is usually delayed and treatment options other than lung transplantation are unfortunately limited. We report the case of 51-year-old female gardener diagnosed with PVOD by open lung biopsy before her death. Although there are many reported cases of hepatic veno-occlusive disease due to toxic agents present in nature, such as pyrrolizidine alkaloid exposure, to date this has not been linked to PVOD